(Q46230541)

20 December 2017

title

The polyphenol piceid destabilizes preformed amyloid fibrils and oligomers in vitro: hypothesis on possible molecular mechanisms (English)

1 reference

20 December 2017

1 reference

Céline Rivière

1

1 reference

20 December 2017

Jean-Claude Delaunay

2

1 reference

20 December 2017

Françoise Immel

3

1 reference

20 December 2017

Christophe Cullin

4

1 reference

20 December 2017

Jean-Pierre Monti

5

1 reference

20 December 2017

publication date

23 November 2008

1 reference

20 December 2017

published in

Neurochemical Research

1 reference

20 December 2017

volume

34

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

1120-1128

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s11064-008-9883-6

exact match

0 references

cites work

A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-008-9883-6

Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-008-9883-6

NMR and simulated annealing investigations of bradykinin in presence of polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-008-9883-6

Role of peptide primary sequence in polyphenol-protein recognition: an example with neurotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-008-9883-6

Polyphenol-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-008-9883-6

Is the C-terminal region of bradykinin the binding site of polyphenols?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-008-9883-6

First observation of solution structures of bradykinin–penta-O-galloyl-d-glucopyranose complexes as determined by NMR and simulated annealing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-008-9883-6

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

21 January 2018

1 reference

12 December 2020

Nicotine and amyloid formation

1 reference

12 December 2020

Polyphenol/peptide binding and precipitation

1 reference

12 December 2020

First observation of solution structures of bradykinin-penta-O-galloyl-D-glucopyranose complexes as determined by NMR and simulated annealing

1 reference

12 December 2020

Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia.

1 reference

12 December 2020

Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity

1 reference

12 December 2020

Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease

1 reference

12 December 2020

Disease modifying therapy for AD?

1 reference

12 December 2020

Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.

1 reference

12 December 2020

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

1 reference

12 December 2020

Protective effect of the xanthate, D609, on Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress in primary neuronal cells

1 reference

12 December 2020

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

12 December 2020

Study of the interaction between salivary proline-rich proteins and a polyphenol by 1H-NMR spectroscopy

1 reference

12 December 2020

Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity

1 reference

12 December 2020

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

12 December 2020

A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state

1 reference

12 December 2020

Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance.

1 reference

12 December 2020

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

12 December 2020

Benefits from dietary polyphenols for brain aging and Alzheimer's disease

1 reference

12 December 2020

The role of polyphenolic compounds in the diet as inhibitors of platelet function

1 reference

12 December 2020

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

12 December 2020

Translating cell biology into therapeutic advances in Alzheimer's disease

1 reference

12 December 2020

3D structure of Alzheimer's amyloid-beta(1-42) fibrils

1 reference

12 December 2020

Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro

1 reference

12 December 2020

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

1 reference

12 December 2020

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

1 reference

12 December 2020

Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein

1 reference

12 December 2020

Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases

1 reference

12 December 2020

Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner

1 reference

12 December 2020

Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity

1 reference

12 December 2020

Multiple conformations of the proline-rich protein/epigallocatechin gallate complex determined by time-averaged nuclear Overhauser effects

1 reference

12 December 2020

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

12 December 2020

Prevention of carcinogenesis by tea polyphenols

1 reference

12 December 2020

Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

1 reference

12 December 2020

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.

1 reference

12 December 2020

Activation of macrophages by Alzheimer beta amyloid peptide.

1 reference

12 December 2020

Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro.

1 reference

12 December 2020

Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril

1 reference

12 December 2020

Amyloid fibrillogenesis: themes and variations

1 reference

12 December 2020

The relationship between the aggregational state of the amyloid-beta peptides and free radical generation by the peptides

1 reference

12 December 2020

Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation

1 reference

12 December 2020

Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins

1 reference

12 December 2020

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

1 reference

12 December 2020

Polyphenols: food sources and bioavailability

1 reference

12 December 2020

Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro

1 reference

12 December 2020

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

1 reference

12 December 2020

Three-dimensional structure and dynamics of wine tannin-saliva protein complexes. A multitechnique approach

1 reference

12 December 2020

Reversible mechanical unzipping of amyloid beta-fibrils

1 reference

12 December 2020

Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide

1 reference

12 December 2020

In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology

1 reference

12 December 2020

A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR

1 reference

12 December 2020

New polyphenols active on beta-amyloid aggregation

1 reference

12 December 2020

Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.

1 reference

12 December 2020

Fresh and nonfibrillar amyloid beta protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AbetaP-channel-mediated cellular toxicity

1 reference

12 December 2020

Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils

1 reference

12 December 2020

Self-assembly of Abeta(1-42) into globular neurotoxins.

1 reference

12 December 2020

Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy

1 reference

12 December 2020

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

12 December 2020

Dietary polyphenols and the prevention of diseases.

1 reference

12 December 2020

Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease

1 reference

12 December 2020

Alzheimer's disease: genotypes, phenotypes, and treatments

1 reference

12 December 2020

The channel hypothesis of Alzheimer's disease: current status

1 reference

12 December 2020

Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes.

1 reference

12 December 2020

Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases

1 reference

12 December 2020

10.1007/S11064-008-9883-6

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19030989

1 reference

20 December 2017